Loading provider…
Loading provider…
Hematology & Oncology Physician in Beverly Hills, CA
NPI: 1457591075Primary Employer
Cedars-Sinai Medical Care Foundation
cedars-sinai.org
HQ Phone
Get MD MBA Kevin's Phone Numberphone_androidMobile
Get MD MBA Kevin's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2009 - 2027

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
City of Hope National Medical Center
Fellowship • Hematology and Medical Oncology
2010 - 2013
New York University School of Medicine
Medical School
Until 2007
UCLA David Geffen School of Medicine/UCLA Medical Center
Internship • Internal Medicine
—
Princeton University
—
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 380 | 987 |
| 2 | 36415Insertion of needle into vein for collection of blood sample | 251 | 511 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 232 | 650 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 76 | 76 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 66 | 66 |
Authors: Nabilah Ali, Zachary Zumsteg, Chrysanta Patio, Alain Mita, Allen Ho, Jon Mallen-St. Clair, Ravi Prasad, Stephen Shiao
Journal: JAMA Oncol
Variations in the association of grade with survival across the head and neck cancer landscape.
Authors: Bonnie Balzer, Zachary Zumsteg, Alain Mita, Diana Lu, Allen Ho, Jon Mallen-St. Clair, Stephen Shiao
Journal: Head Neck
Publication Date: 2020-12-10
Human papillomavirus-associated oropharyngeal cancer among patients aged 70 and older: Dramatically increased prevalence and clinical implications.
Authors: Diana Lu, Allen Ho, Jon Mallen-St. Clair, Mark Sittig
Publication Date: 2018-05-11
Lead Sponsor: Jun Gong, MD
Collaborators: Emmaus Medical, Inc.
Intervention / Treatment: DRUG: Gemcitabine, DRUG: Nab-paclitaxel, DRUG: L-glutamine
Lead Sponsor: Andrew Hendifar, MD
Collaborators: EOC Pharma
Intervention / Treatment: DRUG: Keytruda, DRUG: Telatinib
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Doxorubicin, DRUG: Filgrastim, DRUG: Cisplatin, DRUG: Gemcitabine, DRUG: Methotrexate, DRUG: Vinblastine